Press release from Companies
Publicerat: 2025-07-11 15:28:08
Bio-Works Technologies AB has received an order worth SEK 5.5 million from a leading global pharmaceutical company, with delivery scheduled for Q4 2025. The order covers WorkBeads™ affimAb, a chromatography resin used for antibody purification in commercial manufacturing.
The customer, who has previously used WorkBeads affimAb in several commercial processes, has placed this repeat order as a strong sign of continued confidence in Bio-Works’ products. The order reinforces the ongoing collaboration between the two companies and lays the foundation for a deeper long-term partnership.
WorkBeads affimAb is designed for efficient and selective purification of antibodies and is a highly attractive solution for industrial-scale biopharmaceutical production.
“Receiving a repeat order from a global pharmaceutical leader is a clear validation of our products’ performance in demanding, large-scale processes. It confirms our strategy to be an innovative and trusted partner in biopharmaceutical manufacturing,” says Lone Carlbom, CEO of Bio-Works Technologies AB.
This order reflects Bio-Works’ continued growth and strengthens the company’s position as a strategic supplier to the global biopharmaceutical industry.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 11-07-2025 15:28 CET.
Contacts
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Lone Carlbom, CEO, e-mail: lone.carlbom@bio-works.com phone: +46(0)8-502 705 84.
About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.
Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.
